International formulations drive up Lupin's sales by 17%
This article was originally published in Scrip
Executive Summary
Lupin has reported a 17% increase in net sales to Rs14.67 billion ($322 million) for the third quarter ended December 2010, backed by formulations sales growth in the US, Europe and Japan. Net profit increased by 39% to Rs2.24 billion in the quarter.